Abstract
Vascular calcification due to elevated phosphate levels is the major contributor of cardiovascular dysfunction. The oxidative stress and gene expression events modulate the transdifferentiation of vascular smooth muscle cells into osteogenic phenotype. This present study intends to evaluate the dose-dependent effect of diosgenin, an antioxidant on high phosphate induced vascular calcification in adenine-induced chronic renal failure rats. High phosphate environment causes elevated calcium accumulation with related histological changes and alkaline phosphatase activity in aorta. Further it downregulates the activity of enzymatic antioxidants and elevates the level of lipid peroxidative markers. Moreover, the renal failure leads to reduced nitric oxide production. But, treatment with diosgenin at a dose of 10, 20, and 40 mg/kg given via oral gavages causes reversion of all the above events in a dose-dependent manner. The highest dose has shown more potential activity than other two doses, which has the ability to protect the alteration of liver markers and red blood cell antioxidant system without any adverse effects and it does not alter the kidney associated changes too. Finally, the Fourier transform infrared spectroscopy study strongly supports its ability to protect the macromolecules from oxidative stress. All the above evidences show that diosgenin has overall benefits against renal failure-induced vascular calcification-associated oxidative stress.
Similar content being viewed by others
References
Anderson HC (1983) Calcific diseases. A concept. Arch Pathol Lab Med 107:341–348
Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Investig 91:1800–1809
Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS (2001) Bone formation and inflammation in cardiac valves. Circulation 103:1522–1528
Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weiss-berg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100:2168–2176
Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM (2003) Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23:489–494
Davies JD, Carpenter KL, Challis IR, Figg NL, McNair R, Proudfoot D, Weissberg PL, Shanahan CM (2005) Adipocytic differentiation and liver X receptor pathways regulate the accumulation of triacyl-glycerols in human vascular smooth muscle cells. J Biol Chem 280:3911–3919
Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, Demer LL (2003) Multilineage potential of cells from the artery wall. Circulation 108:2505–2510
Massy ZA, Mazière C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, Slama M, Andrejak M, Mazière JC (2005) Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol 20:380–382
Sherki YG, Rosenbaum Z, Melamed E, Offen D (2006) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54:271–284
Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99:1044–1059
Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T (2012) The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res 27:474–485
Shishodia S, Aggarwal BB (2005) Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression. Oncogene 25:1463–1473
Adlercreutz H, Markkanen H, Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209–1210
Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155:381–386
Figtree GA, Griffiths H, Lu YQ, Webb CM, MacLeod K, Collins P (2000) Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol 35:1977–1985
Au AL, Kwok CC, Lee AT, Kwan YW, Lee MM, Zhang RZ, Ngai SM, Lee SM, He GW, Fung KP (2004) Activation of iberiotoxin-sensitive, Ca2-activated Kchan-nels of porcine isolated left anterior descending coronary artery by diosgenin. Eur J Pharmacol 502:123–133
Choi KW, Park HJ, Jung DH, Kim TW, Park YM, Kim BO, Sohn EH, Moon EY, Um SH, Rhee DK, Pyo S (2010) Inhibition of TNF-α-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via downregulation of the MAPK, Akt and NF-κB signaling pathways. Vasc Pharmacol 53:273–280
Pari L, Monisha P, Jalaludeen AM (2012) Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats. Eur J Pharmacol 691:143–150
Sutliff RL, Walp ER, El-Ali AM, Elkhatib S, Lomashvili KA, O’Neill WC (2011) Effect of medial calcification on vascular function in uremia. Am J Physiol Renal Physiol 301:F78–F83
Zhou Y-B, Jin S-J, Cai Y, Teng X, Chen L, Tang C-S, Qi Y-F (2009) Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats. Exp Biol Med 234:908–917
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138
Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 21:130–132
Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidise. Science 179:588–590
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Niehaus WG, Samuelson B (1968) Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–130
Jiang ZY, Hunt JV, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384–389
Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13:156–159
Caraway WT (1955) Determination of uric acid in serum by carbonate method. Am J Clin Pathol 25:840–845
Jaffe M (1886) Concerning the precipitate produced in normal urine by picric acid and a new reaction of creatinine. Z Physiol Chem 10:391–400
Rosalki SB, Rau D (1972) Serum-glutamyl transpeptidase activity in alcoholism. Clin Chim Acta 39:41–47
Sivakumar S, Sivasubramanian J, Raja B (2012) Aluminium induced structural, metabolic alterations and protective effects of desferrioxamine in the brain tissue of mice: An FTIR study. Spectrochimica Acta Part A 99:252–258. doi:10.1016/j.saa.2012.09.036
Saravanakumar M, Manivannan J, Sivasubramanian J, Silambarasan T, Balamurugan E, Raja B (2012) Molecular metabolic fingerprinting approach to investigate the effects of borneol on metabolic alterations in the liver of nitric oxide deficient hypertensive rats. Mol Cell Biochem 362:203–209
Cakmak G, Togan I, Severcan F (2006) 17-Estradiol induced com-positional, structural and functional changes in rainbow trout liver, revealed by FT-IR spectroscopy: a comparative study with nonyl-phenol. Aquat Toxicol 77:53–63
Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J (2012) Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27:514–521
Shan PF, Lu Y, Cui RR, Jiang Y, Yuan LQ, Liao EY (2011) Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells. PLoS ONE 6(3):e17938. doi:10.1371/journal.pone.0017938
Kapustin A, Galkin A, Furmanik M, Hernandez AD, Shanahan C (2011) Elevated calcium and phosphate impair mitochondrial function in calcifying human vascular smooth muscle cell. Heart 97(24) doi:10.1136/heartjnl-2011-301156.19
Kim H, Kim HJ, Lee K, Kim JM, Kim HS, Kim JR, Ha CM, Choi YK, Lee SJ, Kim JY, Harris RA, Jeong D, Lee IK (2012) α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med 16:273–286
Frank L, Massaro D (1980) Oxygen toxicity. Am J Med 69:117–126
Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM, Chen Y (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 283:15319–15327
Jayachandran KS, Vasanthi HR, Rajamanickam GV (2009) Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction. Mol Cell Biochem 327:203–210
Van TV, Watari E, Taketani Y, Kitamura T, Shiota A, Tanaka T, Tanimura A, Harada N, Nakaya Y, Yamamoto H, Miyamoto K, Takeda E (2012) Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats. J Clin Biochem Nutr 51:27–32
Severcan F (1997) Vitamin E decreases the order of the phospholipids model membranes in the gel phase: an FT-IR study. Biosci Rep 17:231–235
Rice-Evans CA, Diplock AT, Symos MCR (1991) Technique in free radical research. Elsevier, New York, pp 207–218
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manivannan, J., Barathkumar, T.R., Sivasubramanian, J. et al. Diosgenin attenuates vascular calcification in chronic renal failure rats. Mol Cell Biochem 378, 9–18 (2013). https://doi.org/10.1007/s11010-013-1588-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1588-8